KD Logo

Investing in Health Catalyst Inc (HCAT) Is Getting More Attractive

Health Catalyst Inc’s recently made public that its Chief People Officer Llewelyn Linda unloaded Company’s shares for reported $8221.0 on Jun 17 ’24. In the deal valued at $6.37 per share,1,290 shares were sold. As a result of this transaction, Llewelyn Linda now holds 121,154 shares worth roughly $0.74 million.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Then, Alger Jason sold 2,823 shares, generating $19,281 in total proceeds. Upon selling the shares at $6.83, the Chief Financial Officer now owns 118,170 shares.

Before that, Freeman Kevin Lee sold 7,500 shares. Health Catalyst Inc shares valued at $49,008 were divested by the Chief Commercial Officer at a price of $6.53 per share. As a result of the transaction, Freeman Kevin Lee now holds 266,153 shares, worth roughly $1.62 million.

KeyBanc Capital Markets downgraded its Health Catalyst Inc [HCAT] rating to a Sector weight from a an Overweight in a research note published recently. A number of analysts have revised their coverage, including Evercore ISI’s analysts, who increased its forecast for the stock in early January from “an In-line” to “an Outperform”. Barclays began covering HCAT with “an Overweight” recommendation on January 03, 2024. JP Morgan revised its rating on December 13, 2023. It rated HCAT as “an Overweight” which previously was an “a Neutral”.

Price Performance Review of HCAT

On Tuesday, Health Catalyst Inc [NASDAQ:HCAT] saw its stock jump 0.49% to $6.10. Over the last five days, the stock has gained 0.83%. Health Catalyst Inc shares have fallen nearly -34.13% since the year began. Nevertheless, the stocks have fallen -51.20% over the past one year. While a 52-week high of $14.37 was reached on 01/12/24, a 52-week low of $5.45 was recorded on 04/23/24. SMA at 50 days reached $6.45, while 200 days put it at $7.99. A total of 0.44 million shares were traded, compared to the trading of 0.87 million shares in the previous session.

Levels Of Support And Resistance For HCAT Stock

The 24-hour chart illustrates a support level at 6.02, which if violated will result in even more drops to 5.93. On the upside, there is a resistance level at 6.17. A further resistance level may holdings at 6.23. The Relative Strength Index (RSI) on the 14-day chart is 43.39, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.04, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 84.85%. Stochastics%K at 22.66% indicates the stock is a holding.

Most Popular